2022年8月4日

Revecore是一家領先的醫療係統收入完整性和複雜索賠解決方案提供商，宣布它已經收購了兩家專業的收入周期管理公司:總部位於田納西州富蘭克林和新澤西州櫻桃山的Kemberton，以及總部位於佛羅裏達州坦帕的Cura收入周期管理公司。通過這些收購，Revecore繼續執行創建領先的技術支持解決方案組合，以改善全國醫療係統的結果。Revecore首席執行官Dave Wojczynski將領導合並後的公司。Revecore首席執行官Dave Wojczynski表示:“我們處於一個獨特的位置，可以將擁有共同以客戶為中心的願景和價值主張的公司聚集在一起，部署一係列廣泛的技術驅動解決方案，優化工作流程，解決衛生係統最複雜的索賠和報銷挑戰。”“通過將高效的技術平台與業內最有才華和經驗豐富的專家相結合，我們能夠為醫療保健提供商提供更大的價值和回報。我們都擁有包容的文化和為客戶服務的熱情。這增強了我們共同解決最具挑戰性的收入周期問題的能力。我相信這一戰略結合將為我們的客戶帶來更好的財務結果。Cura Revenue Cycle Management現任首席執行官Mark McVeety表示:“將這些公司與互補的技術和專業知識結合起來的機會非常誘人。”“Revecore在收入完整性和複雜索賠解決方案方麵有著出色的記錄。我們都有客戶第一的文化，我很高興能繼續加強我們的聯合能力，為客戶提供成果。” “Teaming up with Revecore is a great next step in the evolution of the RCM industry,” said George Abatjoglou, current CEO of Kemberton. “With decades of experience and knowledge, the scale and capabilities of the combined organization will unlock greater opportunities to deliver best-in-class solutions that will not only benefit all of our combined clients but also enhance the patient-provider relationship.” LLR Partners is a current investor in Kemberton and will retain a minority equity interest in Revecore as a part of the transaction. Revecore is supported by its institutional shareholders GrowthCurve Capital, which completed its acquisition of Revecore in April 2022, and Riverside Partners, which continues to be a significant investor in the business alongside GrowthCurve and management. Vignesh Aier, Head of Healthcare Investing at GrowthCurve Capital, commented on behalf of the investors, “We are excited to support Revecore in making these strategic acquisitions. We believe the capabilities, scale, and technologies these companies bring will help Revecore continue strengthening its position as a leading provider of specialized revenue cycle management services for the country’s leading health systems.” Revecore, GrowthCurve, and Riverside Partners were advised by TripleTree as financial advisor; McDermott Will & Emory and Davis Polk as legal counsels; and Alvarez & Marsal as financial and operational advisor. Cura was represented by Robinson+Cole, and Kemberton was represented by Goodwin Proctor.